Sleep-Promoting Alzheimer’s Study

Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-ranging study of Piromelatine in patients with mild dementia due to Alzheimer’s Disease.  (This study is promoted as helping AD with sleep. )

Has a reliable caregiver

Age 60-85

Currently on a stable dose of Alzheimer’s Disease medication

Has the ability to spend at least 2 hours per day exposed to daylight

  • * Required Field

    Submission of this form does not guarantee your enrollment in any study, but it does let us know you have an interest in participating.

  • This field is for validation purposes and should be left unchanged.